<DOC>
	<DOCNO>NCT01597050</DOCNO>
	<brief_summary>The purpose study determine safety , efficacy tolerability topical R333 ointment Discoid Lupus Erythematosus ( DLE ) Systemic Lupus Erythematosus ( SLE ) patient active discoid lesion .</brief_summary>
	<brief_title>Safety Efficacy Topical R333 Patients With Discoid Lupus Erythematosus ( DLE ) Systemic Lupus Erythematosus ( SLE ) Lesions</brief_title>
	<detailed_description>This Phase 2 , multi-center , randomize , double-blind , placebo-controlled study evaluate preliminary efficacy , safety , tolerability , pharmacokinetics topical R333 ointment formulate 6 % ( 60 mg/g ) DLE SLE patient active discoid lesion .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Lupus Erythematosus , Discoid</mesh_term>
	<criteria>Diagnosis SLE DLE ( DLE confirm histologically prior randomization ) . At least 2 active discoid lesion secondary SLE DLE prior study entry , minimum Erythema Rating Score ≥ 2 . At least 1 active discoid lesion must present ( history ) ≥ 3 week prior screen . Patients take azathioprine , hydroxychloroquine , chloroquine , quinacrine , methotrexate , and/ oral glucocorticoid , must receive stable daily dose ≥ 4 week prior randomization must remain dose throughout study . Azathioprine , hydroxychloroquine , chloroquine , quinacrine , methotrexate must initiate ≥ 8 week prior randomization . Congenital acquire immunodeficiency include : HIV infection , agammaglobulinemia , T cell deficiency HTLV1 infection time prior study . Lymphoproliferative disease previous total lymphoid irradiation . Uncontrolled poorly control hypertension . History psoriasis , eczema , relevant atopy . Exposure excessive chronic UV radiation ( e.g. , tan bed , sunbathe , solarium , phototherapy ) within 2 week prior randomization study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Discoid Lupus Erythematosus</keyword>
	<keyword>Systemic Lupus Erythematosus</keyword>
</DOC>